Navigation Links
First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
Date:11/19/2007

SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Preliminary data from the IMPACT study are being presented today at the Gerontological Society of America's annual conference. The purpose of the IMPACT ("Improvement in Memory with Plasticity-based Adaptive Cognitive Training") study was to evaluate whether improvements from cognitive training can extend to untrained measures of memory performance and to self-perceived everyday cognition.

The IMPACT trial compares the benefits of a plasticity-based cognitive training program (the Posit Science Brain Fitness Program) to a computer-based learning control matched for computer usage and training intensity. It was chosen to represent current clinical recommendations regarding "staying cognitively active." The IMPACT study is the first large-scale randomized controlled trial of a non-invasive, computer-based cognitive intervention for aging adults that is available for widespread, individual use. In addition to using standardized neuropsychological tests to assess training-related changes in memory, the IMPACT study measured the improvements in cognitive abilities directly reported by study participants themselves.

Using an intensive series of adaptive computerized exercises, the Brain Fitness Program is designed to target the speed and accuracy of auditory and language processes, and neuromodulatory systems associated with learning and memory. Predefined endpoints distinct in design and content from training exercises included standardized neuropsychological assessments of memory and participant-reported outcome (PRO) assessments measuring perceptions of everyday cognition.

After 10 weeks of training, significant group by time interactions favoring the experimental group (the Brain Fitness Program) were seen on the primary endpoint measure (RBANS Auditory Memory) and multiple within-modality but not cross-modality secondary endpoint measures. PRO measures of everyday cognitive function were significant on pre-post and post-only assessments.

Principal Investigators Glenn Smith, PhD at Mayo Clinic and Elizabeth Zelinski, PhD at the University of Southern California, participated in this prospective, randomized, controlled trial. The study involved 524 healthy adults over the age of 65.

About Posit Science

Posit Science Corporation develops science-based brain health programs. The company works with more than 50 brain scientists from leading universities around the world to create training programs that enhance cognitive performance. Its assessments and exercises are based on neuroplasticity -- the brain's ability to "rewire" through intensive, repetitive and progressively challenging activity. The company's Brain Fitness Program is distributed without charge by Humana to its Medicare Advantage members, is licensed to more than 150 retirement communities nationwide, is sold online and by Authorized Providers. Posit Science has received several grants from the National Institutes of Health (NIH). Posit Science was named "Best Small Company" by the American Society on Aging, was named "Best Fitness Initiative" by the Consumer Health World Conference and was selected as one of the "medical breakthroughs of the year" by CNBC. For more information visit http://www.PositScience.com or call 800.514.3975.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: